Hepatitis Forums

Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on May 20, 2020, 11:21:24 am

Title: Many People Who Start Hepatitis C Treatment Are Lost to Follow-Up
Post by: Hep Editors on May 20, 2020, 11:21:24 am

Among people who start direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV), a substantial proportion do not maintain all their follow-up appointments.

Publishing their findings in the Journal of Viral Hepatology, Canadian researchers analyzed data from the British Columbia Hepatitis Testers Cohort on 4,777 people who started DAAs.

The study included people with genotype 1 of HCV who were treated with Harvoni (ledipasvir/sofosbuvir), with or without ribavirin, or the Viekira regimen (ombitasvir/paritaprevir/ritonavir; dasabuvir), with or without ribavirin, and people with genotype 3 who were treated with Sovaldi (sofosbuvir) plus ribavirin through the end of 2017.

For more...
https://www.hepmag.com/article/many-people-start-hepatitis-c-treatment-lost-followup